Sponsored message
Logged in as
Audience-funded nonprofit news
radio tower icon laist logo
Next Up:
0:00
0:00
Subscribe
  • Listen Now Playing Listen

This archival content was originally written for and published on KPCC.org. Keep in mind that links and images may no longer work — and references may be outdated.

KPCC Archive

CA to test HIV treatment pill for possible preventative use

SAN ANSELMO, CA - NOVEMBER 23:  A pharmacist pours Truvada pills back into the bottle at Jack's Pharmacy on November 23, 2010 in San Anselmo, California.  A study published by the New England Journal of Medicine showed that men who took the daily antiretroviral pill Truvada significantly reduced their risk of contracting HIV. (Photo Illustration by Justin Sullivan/Getty Images)
A pharmacist pours Truvada pills back into the bottle in San Anselmo, California. New grants will fund a study into whether the pill can be used as an HIV preventative.
(
Justin Sullivan/Getty Images
)

One year ago, Congress defunded public media. Now that we're 100% community funded, please become a sustaining member or increase your existing membership today.

A pill which has long served as treatment for the HIV-positive may now work on double-duty as an HIV preventative. Researchers announced Tuesday that they will be testing the pill as a preventative in about 700 gay and bisexual men, and transgendered women, in the Los Angeles and SoCal area.

"The ideal candidate for this kind of pill would be somebody who is repeatedly at high risk of infection," said Phil Curtis, director of government affairs for AIDS Project Los Angeles. The nonprofit will be helping to recruit study participants.

According to Curtis, studies have shown up to a 90 percent drop in new infections among high-risk subjects using the drug, under the brand name Truvada. The drug has already been approved by the FDA for treating HIV, but not for preventative use.

Curtis says that Gilead Sciences, who produces the drug, has applied to get the new use approved.

The California HIV/AIDS Research Program has awarded $11.8 million in state grants for preventative pill studies, including the one involving Truvada.

"The California and L.A. County AIDS epidemic is significantly driven by men," says Curtis. "[Gay men] account for 80-85 percent of all HIV positive cases."

According to the Center for Aids Research and Education Purposes, California has the second highest HIV/AIDS incidence rate in the U.S. after New York.

Sponsored message

Over two-thirds of all of those in California living with HIV live in L.A. County or the San Francisco Bay Area.

The Truvada study will last four years before any results are announced.

One year ago, Congress voted to defund public media, eliminating a critical $1.7 million from our budget every year going forward. But they couldn’t silence us, and we’re not going anywhere. LAist is now 100% community funded and that means we’re taking our future into our own hands and turning to you to keep local reporting strong.

You come to LAist because you want independent reporting and trustworthy local information. Our nonprofit newsroom doesn’t answer to shareholders looking to turn a profit. Instead, we answer to you and our communities. We are free to follow facts wherever they lead and to hold power to account without fear or favor. Our only loyalty is to our readers and listeners and our mission: to inform, engage, and strengthen Southern California’s communities.

If this story helped you, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.
Senior Vice President News, Editor in Chief

Make your tax-deductible donation today